Unknown

Dataset Information

0

Gestational toxoplasmosis treatment changes the child's prognosis: A cohort study in southern Brazil.


ABSTRACT:

Background

We evaluate the drug treatment for pregnant women with acute toxoplasmosis to reduce the risk of congenital infection, side effects (prenatal and postnatal treatment in children) and the hazard of discontinuing the infant's medication.

Methods

We conducted a prospective cohort study to assess the risks of congenital toxoplasmosis among children born to acutely infected women with and without treatment. We examined the relationship between "exposed" and "infected children", "number of infant neutrophils", "prenatal" and "postnatal treatment". Factor analysis of mixed data (FAMD) was used to analyze the data. All children started treatment at the hospital.

Findings

Between 2017 and 2021, 233 pregnant women were evaluated at the University Hospital of Maringá; ninety-four met criteria for acute gestational toxoplasmosis. We followed up 61 children; eleven (18%) had the infection confirmed and 50 (82%) were free of toxoplasmosis (exposed). Children born to untreated mothers have 6.5-times higher risk of being infected; the transmission rate among untreated mothers was 50% versus 8.3% among treated ones. Three decreasing values of immunoglobulin G were a security parameter for stopping the child's medication in the exposed group (50/61). Neutropenia was the leading side effect among children and the infected had a 2.7 times higher risk. There was no correlation between maternal use of pyrimethamine and children's neutropenia.

Interpretation

The follow-up of women with acute T. gondii infection and their children, through a multidisciplinary team, availability of anti-T. gondii serology and pre- and post-natal treatments reduced the risk of toxoplasmosis transmission.

SUBMITTER: Gomes Ferrari Strang AG 

PROVIDER: S-EPMC10593203 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Gestational toxoplasmosis treatment changes the child's prognosis: A cohort study in southern Brazil.

Gomes Ferrari Strang Ana Gabriela AG   Ferrar Rafaela Gomes RG   Falavigna-Guilherme Ana Lúcia AL  

PLoS neglected tropical diseases 20230929 9


<h4>Background</h4>We evaluate the drug treatment for pregnant women with acute toxoplasmosis to reduce the risk of congenital infection, side effects (prenatal and postnatal treatment in children) and the hazard of discontinuing the infant's medication.<h4>Methods</h4>We conducted a prospective cohort study to assess the risks of congenital toxoplasmosis among children born to acutely infected women with and without treatment. We examined the relationship between "exposed" and "infected childre  ...[more]

Similar Datasets

| S-EPMC6992202 | biostudies-literature
| S-EPMC2953528 | biostudies-literature
| S-EPMC9607592 | biostudies-literature
| S-EPMC10840208 | biostudies-literature
| S-EPMC10261112 | biostudies-literature
| S-EPMC4303430 | biostudies-other
| S-EPMC6679740 | biostudies-literature
| S-EPMC2493041 | biostudies-literature
| S-EPMC6003971 | biostudies-literature
| S-EPMC8300179 | biostudies-literature